Skip to main content
Clinical Trials/CTRI/2024/07/070144
CTRI/2024/07/070144
Not yet recruiting
Phase 2

A Randomized controlled clinical Trial to study the efficacy of Thyrocompound in the management of Subclinical Hypothyroidism. - nil

Dr Varsharani Arjun Chaudhari0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Varsharani Arjun Chaudhari
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Varsharani Arjun Chaudhari

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of grade 1 subclinical hypothyroidism having serum TSH level within range of 4\.9 mL/L to 10 mL/L.
  • 2\.Patients having 3 clinical symptoms of subclinical hypothyroidism among following\-
  • tiredness weakness lethargy dry skin and hair cold intolerance loss of hairs difficulty in concentration and poor memory weight gain with poor appetite constipation hoarseness of voice dypsonea menorrhagia puffy face hands and feet bradycardia

Exclusion Criteria

  • 1\. Grade 2 subclinical hypothyroidism serum TSH level more than 10 mL/L.
  • 2\. Primary hypothyroidism caused due to thyroidectomy radioactive Iodine Therapy for Graves disease or Nodular Goiter. Radio therapy for head and neck cancer.
  • 3\. Secondary hypothyroidism
  • 4\. Patients Having history of medications like Amiodarone, Interleukin \-2 Kinase inhibitor and lithium
  • 5\. Patients undergoing any known hormonal therapy other than Levothyroxine
  • 6\. Patients suffering from chronic anemia
  • 7\. Co morbid patients like known case of HTN, DM, IHD, Angina , MI
  • 8\. Patients receiving anti retro viral therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials